# Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers

> **NCT00536679** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (actual)

## Conditions studied

- Depressive Disorder and Anxiety Disorders

## Interventions

- **DRUG:** GSK163090 capsule, fasted
- **DRUG:** GSK163090 Tablet, fasted
- **DRUG:** GSK163090 Tablet, fed

## Key facts

- **NCT ID:** NCT00536679
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09-20
- **Primary completion:** 2007-11-05
- **Final completion:** 2007-11-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00536679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00536679, "Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00536679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*